Average Co-Inventor Count = 2.56
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Michigan (26 from 3,370 patents)
2. Genzyme Corporation (4 from 787 patents)
26 patents:
1. 11220479 - Glucosylceramide synthase inhibitors and therapeutic methods using the same
2. 10202340 - Glucosylceramide synthase inhibitors and therapeutic methods using the same
3. 10111937 - Method of reducing accumulation of intracellular tingible body macrophages
4. 9309553 - Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus
5. 8961959 - Glucosylceramide synthase inhibitors and therapeutic methods using the same
6. 8052970 - Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
7. 7615573 - Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
8. 7582442 - Methods and compositions for using aleveolar macrophage phospholipase A2
9. 7335681 - Amino ceramide-like compounds and therapeutic methods of use
10. 7319015 - Methods and compositions for using alveolar macrophage phospholipase A2
11. 7253185 - Amino ceramide-like compounds and therapeutic methods of use
12. 7196205 - [object Object]
13. 7148251 - Amino ceramide-like compounds and therapeutic methods of use
14. 6916802 - Amino ceramide-like compounds and therapeutic methods of use
15. 6890949 - Amino ceramide-like compounds and therapeutic methods of use